e-Therapeutics working to capitalise on AI "blindside"
News release
by
e-Therapeutics PLC
London, UK
|
May 04, 2023 08:20 AM Eastern Daylight Time
e-Therapeutics PLC (AIM:ETX OTCQX:ETXPF) CEO Ali Mortazavi speaks to Thomas Warner following the release of the computational biology and chemistry company's full year results for 2022. Mortazavi says that it was a "tricky year for the biotechnology sector as a whole" but that eTherapeutics has shown "remarkable resilience."
He goes on to highlight the opportunity being presented to the company by the advent of large language models (LLMs) and GPT-4, saying that he's never before seen a technology "blindside the world" to such an extent.
Contact Details
Proactive UK Ltd
Proactive UK Ltd
+44 20 7989 0813
